← All trials
NCT04001075
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 25, 2019
- Primary completion
- Jun 30, 2021
- Completion date
- Sep 23, 2021
- First posted
- Jun 27, 2019
- Last posted
- Oct 14, 2022
- Enrollment
- 32
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- I-Mab BiopharmaLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.